Alzheimer’s disease: the new promise.
Publication
, Journal Article
Strittmatter, WJ
Published in: J Clin Invest
April 2012
Clinical vignette: A 59-year-old aeronautical engineer is referred to you for evaluation because of increasing difficulty with job performance over the last several years. Difficulty managing home finances, getting lost driving, and forgetting appointments have become common. Previously outgoing, he is now depressed and irritable. After appropriate neurologic assessment, including brain imaging and metabolic studies, you make the diagnosis of Alzheimer’s dementia and are asked by the patient’s family what treatment is available.
Duke Scholars
Altmetric Attention Stats
Dimensions Citation Stats
Published In
J Clin Invest
DOI
EISSN
1558-8238
Publication Date
April 2012
Volume
122
Issue
4
Start / End Page
1191
Location
United States
Related Subject Headings
- Venoms
- Peptides
- Male
- Insulin-Like Growth Factor I
- Insulin Resistance
- Insulin Receptor Substrate Proteins
- Insulin
- Immunology
- Hypoglycemic Agents
- Humans
Citation
APA
Chicago
ICMJE
MLA
NLM
Strittmatter, W. J. (2012). Alzheimer’s disease: the new promise. J Clin Invest, 122(4), 1191. https://doi.org/10.1172/jci62745
Strittmatter, Warren J. “Alzheimer’s disease: the new promise.” J Clin Invest 122, no. 4 (April 2012): 1191. https://doi.org/10.1172/jci62745.
Strittmatter WJ. Alzheimer’s disease: the new promise. J Clin Invest. 2012 Apr;122(4):1191.
Strittmatter, Warren J. “Alzheimer’s disease: the new promise.” J Clin Invest, vol. 122, no. 4, Apr. 2012, p. 1191. Pubmed, doi:10.1172/jci62745.
Strittmatter WJ. Alzheimer’s disease: the new promise. J Clin Invest. 2012 Apr;122(4):1191.
Published In
J Clin Invest
DOI
EISSN
1558-8238
Publication Date
April 2012
Volume
122
Issue
4
Start / End Page
1191
Location
United States
Related Subject Headings
- Venoms
- Peptides
- Male
- Insulin-Like Growth Factor I
- Insulin Resistance
- Insulin Receptor Substrate Proteins
- Insulin
- Immunology
- Hypoglycemic Agents
- Humans